DDFM vs. BOUT
DDFM (Innovator Equity Dual Directional 15 Buffer ETF - March) and BOUT (Innovator IBD Breakout Opportunities ETF) are both exchange-traded funds - DDFM is a Defined Outcome fund tracking the SPDR S&P 500 ETF Trust (SPY), while BOUT is a Mid Cap Growth Equities fund tracking the IBD Breakout Stocks Total Return Index. Both are passively managed. A 0.67 correlation means they provide meaningful diversification when combined. DDFM charges 0.79%/yr vs 0.80%/yr for BOUT.
Performance
DDFM vs. BOUT - Performance Comparison
Loading charts...
Returns By Period
DDFM
- 1D
- 0.10%
- 1M
- 1.05%
- YTD
- —
- 6M
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
BOUT
- 1D
- -0.19%
- 1M
- 2.96%
- YTD
- 31.14%
- 6M
- 29.42%
- 1Y
- 34.29%
- 3Y*
- 17.47%
- 5Y*
- 8.21%
- 10Y*
- —
DDFM vs. BOUT - Yearly Performance Comparison
| 2026 (YTD) | |
|---|---|
DDFM Innovator Equity Dual Directional 15 Buffer ETF - March | 3.27% |
BOUT Innovator IBD Breakout Opportunities ETF | 14.95% |
Correlation
The correlation between DDFM and BOUT is 0.67, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Mar 3, 2026 | 0.67 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
DDFM vs. BOUT — Risk / Return Rank
DDFM
BOUT
DDFM vs. BOUT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Innovator Equity Dual Directional 15 Buffer ETF - March (DDFM) and Innovator IBD Breakout Opportunities ETF (BOUT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
Loading charts...
Sharpe Ratios by Period
| DDFM | BOUT | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | — | 1.66 | — |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | 0.42 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 2.24 | 0.41 | +1.83 |
Drawdowns
DDFM vs. BOUT - Drawdown Comparison
The maximum DDFM drawdown since its inception was -3.09%, smaller than the maximum BOUT drawdown of -36.75%. Use the drawdown chart below to compare losses from any high point for DDFM and BOUT.
Loading charts...
Drawdown Indicators
| DDFM | BOUT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -3.09% | -36.75% | +33.66% |
Max Drawdown (1Y)Largest decline over 1 year | — | -11.76% | — |
Max Drawdown (3Y)Largest decline over 3 years | — | -25.31% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -28.28% | — |
Current DrawdownCurrent decline from peak | 0.00% | -0.19% | +0.19% |
Average DrawdownAverage peak-to-trough decline | -0.52% | -12.29% | +11.77% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 3.93% | — |
Volatility
DDFM vs. BOUT - Volatility Comparison
Loading charts...
Volatility by Period
| DDFM | BOUT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 5.46% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 16.00% | — |
Volatility (1Y)Calculated over the trailing 1-year period | 5.89% | 20.78% | -14.89% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 5.89% | 19.48% | -13.59% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 5.89% | 22.93% | -17.04% |
DDFM vs. BOUT - Expense Ratio Comparison
DDFM has a 0.79% expense ratio, which is lower than BOUT's 0.80% expense ratio.
Dividends
DDFM vs. BOUT - Dividend Comparison
DDFM has not paid dividends to shareholders, while BOUT's dividend yield for the trailing twelve months is around 0.26%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
BOUT Innovator IBD Breakout Opportunities ETF | 0.26% | 0.34% | 0.60% | 1.32% | 1.35% | 0.00% | 0.00% | 0.00% | 0.22% |
DDFM Innovator Equity Dual Directional 15 Buffer ETF - March | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
DDFM and BOUT have a correlation of 0.67, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, DDFM is cheaper at 0.79% per year. The better choice depends on whether you care most about return, fees, risk, or income.
DDFM is cheaper with a 0.79% expense ratio, compared with 0.80% for BOUT.
BOUT has the higher dividend yield at 0.26%, compared with 0.00% for DDFM.
DDFM is categorized as Defined Outcome, while BOUT is Mid Cap Growth Equities. DDFM tracks SPDR S&P 500 ETF Trust (SPY), while BOUT tracks IBD Breakout Stocks Total Return Index. Their fees differ too: 0.79% for DDFM and 0.80% for BOUT.
Find the right allocation for DDFM and BOUT
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer